Construction of a predictive model for acute liver failure after hepatectomy based on neutrophil-to-lymphocyte ratio and albumin-bilirubin score

Figure 1 Experimental flow chart. ALF: Acute liver failure.

Figure 2 Comparison of the differences between the acute liver failure group and non-acute liver failure group. A: Neutrophil-to-lymphocyte ratio; B: Albumin-bilirubin score. ^aP < 0.05. ALF: Acute liver failure.

Figure 3 Receiver operating characteristic curves of predicting the occurrence of acute liver failure after R0 surgery for hepatocellular carcinoma. A: Acute liver failure; B: Blood loss volume; C: Neutrophil-to-lymphocyte ratio; D: Albumin-bilirubin score. AFP: Acute liver failure; BLV: Blood loss volume; NLR: Neutrophil-to-lymphocyte ratio; ALBI: Albumin-bilirubin score; AUC: Area under the curve.

Figure 4 Nomogram prediction model for the occurrence of acute liver failure after R0 surgery for hepatocellular carcinoma. AFP: Acute liver failure; BLV: Blood loss volume; NLR: Neutrophil-to-lymphocyte ratio; ALBI: Albumin-bilirubin score.

Figure 5 Evaluation of the nomogram prediction model. A: Receiver operating characteristic curve; B: Calibration curve; C: Decision curve analysis. AUC: Area under the curve.